Sino Medical Sciences Technology Gets US FDA's Pre-Market Approval for Drug-Eluting Stent

MT Newswires

Sino Medical Sciences Technology received pre-market approval for the application for its new drug-eluting stent in the US, according to a Shanghai bourse filing on Tuesday.

The US Food and Drug Administration will issue the formal approval after the Chinese pharmaceutical company completes certain follow-up requirements.

The company's shares dropped less than 4% at the close of Tuesday's trade.

Risk Warnings and Disclaimers

You understand and acknowledge that there is a high degree of risk involved in trading. Following any strategies or investment methods may lead to potential losses. The content on the site is provided by our contributors and analysts for information purposes only. You are solely responsible for determining whether any trading assets, securities, strategy, or any other product is suitable for investing based on your own investment objectives and financial situation.

Add to Favorites

Sino Medical Sciences Technology Gets Nod to Register Two Devices in Mexico

MT Newswires

688108

-2.12%

Sino Medical Sciences Technology received approval from Mexico's health regulator to register two of its devices, according to a Shanghai Stock Exchange filing on Saturday.

The approvals are for the medical device manufacturer's SC Honkytonk coronary balloon dilatation catheter and NCROCKSTAR non-compliant balloon dilatation catheter, the filing said.

Risk Warnings and Disclaimers

Add to Favorites

Sino Medical Sciences Technology Gets Nod to Register Two Devices in Mexico

MT Newswires

688108

-2.12%

Sino Medical Sciences Technology received approval from Mexico's health regulator to register two of its devices, according to a Shanghai Stock Exchange filing on Saturday.

The approvals are for the medical device manufacturer's SC Honkytonk coronary balloon dilatation catheter and NCROCKSTAR non-compliant balloon dilatation catheter, the filing said.

Risk Warnings and Disclaimers

Add to Favorites

Sino Medical Sciences Technology Secures Regulatory Approvals in Argentina, Ecuador for Medical Devices

MT Newswires

688108

-2.12%

Sino Medical Sciences Technology received regulatory approvals from Argentina and Ecuador for its HT Supreme drug-eluting stent system and related coronary devices.

The devices are designed for coronary artery treatment and feature advanced biodegradable coatings, according to a Friday filing with the Shanghai bourse.

Shares of the medical device manufacturer closed 7% higher Friday.

Risk Warnings and Disclaimers

Add to Favorites

Sino Medical Sciences Technology Secures Regulatory Approvals in Argentina, Ecuador for Medical Devices

MT Newswires

688108

-2.12%

Sino Medical Sciences Technology received regulatory approvals from Argentina and Ecuador for its HT Supreme drug-eluting stent system and related coronary devices.

The devices are designed for coronary artery treatment and feature advanced biodegradable coatings, according to a Friday filing with the Shanghai bourse.

Shares of the medical device manufacturer closed 7% higher Friday.

Risk Warnings and Disclaimers

Add to Favorites

Sino Medical Sciences Technology Gets Malaysia's Nod to Market NC ROCKSTAR Catheter

MT Newswires

688108

-2.12%

Sino Medical Sciences Technology obtained approval from Malaysia's Medical Device Authority for the registration of its NC ROCKSTAR non-compliant balloon dilatation catheter, according to a Shanghai Stock Exchange disclosure on Thursday.

The Chinese medical device manufacturer will be allowed to market the product, which is used to improve myocardial perfusion in patients with atherosclerosis, the disclosure said.

The company's shares rose more than 2% in recent trade.

Risk Warnings and Disclaimers

Add to Favorites

Sino Medical Sciences Technology Gets Malaysia's Nod to Market NC ROCKSTAR Catheter

MT Newswires

688108

-2.12%

The Chinese medical device manufacturer will be allowed to market the product, which is used to improve myocardial perfusion in patients with atherosclerosis, the disclosure said.

The company's shares rose more than 2% in recent trade.

Risk Warnings and Disclaimers

Add to Favorites

Risk Disclosure

The risk of loss in trading financial instruments such as stocks, FX, commodities, futures, bonds, ETFs and crypto can be substantial. You may sustain a total loss of the funds that you deposit with your broker. Therefore, you should carefully consider whether such trading is suitable for you in light of your circumstances and financial resources.

No decision to invest should be made without thoroughly conducting due diligence by yourself or consulting with your financial advisors. Our web content might not suit you since we don't know your financial conditions and investment needs. Our financial information might have latency or contain inaccuracy, so you should be fully responsible for any of your trading and investment decisions. The company will not be responsible for your capital loss.

Without getting permission from the website, you are not allowed to copy the website's graphics, texts, or trademarks. Intellectual property rights in the content or data incorporated into this website belong to its providers and exchange merchants.

Recent Searches

Top Searches

Markets

News

Analysis

User

24/7

Economic Calendar

Education

Data

Sino Medical Sciences Technology Gets US FDA's Pre-Market Approval for Drug-Eluting Stent

Sino Medical Sciences Technology Gets Nod to Register Two Devices in Mexico

Sino Medical Sciences Technology Gets Nod to Register Two Devices in Mexico

Sino Medical Sciences Technology Secures Regulatory Approvals in Argentina, Ecuador for Medical Devices

Sino Medical Sciences Technology Secures Regulatory Approvals in Argentina, Ecuador for Medical Devices

Sino Medical Sciences Technology Gets Malaysia's Nod to Market NC ROCKSTAR Catheter

Sino Medical Sciences Technology Gets Malaysia's Nod to Market NC ROCKSTAR Catheter

Risk Disclosure